Department of Infectious Diseases, The First Affiliated Hospital, China Medical University, Shenyang City, Liaoning Province, People's Republic of China.
The Sixth People's Hospital of Shenyang, Shenyang City, Liaoning Province, People's Republic of China.
Am J Physiol Renal Physiol. 2018 May 1;314(5):F942-F955. doi: 10.1152/ajprenal.00433.2016. Epub 2018 Jan 10.
We have reported that tumor necrosis factor-α (TNF-α) is critical for reduction of glomerular filtration rate (GFR) in rats with fulminant hepatic failure (FHF). The present study aims to evaluate the underlying mechanisms of decreased GFR during acute hepatic failure. Rats with FHF induced by d-galactosamine plus lipopolysaccharide (GalN/LPS) were injected intravenously with recombinant lentivirus harboring short hairpin RNA against the protein kinase C-α ( PKC-α) gene (Lenti-shRNA-PKC-α). GFR, serum levels of aminotransferases, creatinine, urea nitrogen, potassium, sodium, chloride, TNF-α, and endothelin-1 (ET-1), as well as type 1 inositol 1,4,5-trisphosphate receptor (IPR1) expression in renal tissue were assessed. The effects of PKC-α silencing on TNF-α-induced IPR1, specificity protein 1 (SP-1), and c-Jun NH-terminal kinase (JNK) expression, as well as cytosolic calcium content were determined in glomerular mesangial cell (GMCs) with RNAi against PKC-α. Renal IPR1 overexpression was abrogated by pre-treatment with Lenti-shRNA-PKC-α. The PKC-α silence significantly improved the compromised GFR, reduced Cr levels, and reversed the decrease in glomerular inulin space and the increase in glomerular calcium content in GalN/LPS-exposed rats. TNF-α treatment increased expression of PKC-α, IPR1, specificity protein 1 (SP-1), JNK, and p-JNK in GMCs and increased Ca release and binding activity of SP-1 to the IPR1 promoter. These effects were blocked by transfection of siRNA against the PKC-α gene, and the PKC-α gene silence also restored cytosolic Ca concentration. RNAi targeting PKC-α inhibited TNF-α-induced IPR1 overexpression and in turn improved compromised GFR in the development of acute kidney injury during FHF in rats.
我们曾报道,肿瘤坏死因子-α(TNF-α)在暴发性肝衰竭(FHF)大鼠肾小球滤过率(GFR)降低中起关键作用。本研究旨在评估急性肝衰竭期间 GFR 降低的潜在机制。采用 D-半乳糖胺加脂多糖(GalN/LPS)诱导大鼠 FHF,并静脉注射携带针对蛋白激酶 C-α(PKC-α)基因的短发夹 RNA 的重组慢病毒(Lenti-shRNA-PKC-α)。评估 GFR、血清转氨酶、肌酐、尿素氮、钾、钠、氯、TNF-α 和内皮素-1(ET-1)水平,以及肾组织中 1 型肌醇 1,4,5-三磷酸受体(IPR1)的表达。用 RNAi 沉默 PKC-α 对 TNF-α诱导的 IPR1、特异性蛋白 1(SP-1)和 c-Jun NH2-末端激酶(JNK)表达以及细胞浆钙含量的影响,以及用 RNAi 沉默 PKC-α 对肾小球系膜细胞(GMCs)中 TNF-α诱导的 IPR1、特异性蛋白 1(SP-1)和 c-Jun NH2-末端激酶(JNK)表达及细胞浆钙含量的影响。预先用 Lenti-shRNA-PKC-α 处理可消除肾 IPR1 过表达。PKC-α 沉默显著改善受损的 GFR,降低 Cr 水平,并逆转 GalN/LPS 暴露大鼠肾小球中己糖胺空间减少和钙含量增加。TNF-α 处理增加了 GMC 中 PKC-α、IPR1、特异性蛋白 1(SP-1)、JNK 和 p-JNK 的表达,并增加了 Ca 释放和 SP-1 与 IPR1 启动子的结合活性。这些作用被针对 PKC-α 基因的 siRNA 转染阻断,PKC-α 基因沉默也恢复了细胞浆 Ca 浓度。针对 PKC-α 的 RNAi 抑制了 TNF-α 诱导的 IPR1 过表达,从而改善了大鼠 FHF 急性肾损伤发展过程中受损的 GFR。